SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14C - Other definitive information statements:
SEC Accession No. 0001193125-20-061635
Filing Date
2020-03-04
Accepted
2020-03-04 16:18:35
Documents
1
Period of Report
2020-04-13
Effectiveness Date
2020-03-04

Document Format Files

Seq Description Document Type Size
1 DEF 14C d895181ddef14c.htm DEF 14C 562684
  Complete submission text file 0001193125-20-061635.txt   563733
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14C | Act: 34 | File No.: 001-38137 | Film No.: 20687398
SIC: 2834 Pharmaceutical Preparations